click below to choose a session for viewing for webcast help click here
Welcome and Introduction: Redefining the Efficacy for PCI and Management of Acute Coronary Syndromes
Program Chairman:
Steven V.
Manoukian
, M.D., F.A.C.C.
Taking the HIT (Heparin-Induced Thrombocytopenia)
Gary L.
Schaer
, M.D., F.A.C.C.
PERSPICUITY on ACUITY: An Evolving Landmark Trial for High Risk ACS Patients -- Will One Antithrombin Agent Fit All?
Charles V.
Pollack
, Jr, MA, MD,FACEP
To Bleed or Not to Bleed: That is the Question -- The Central Role of Bleeding Minimization and Transfusion Avoidance in Patients Undergoing PCI
Steven V.
Manoukian
, M.D., F.A.C.C.
All the Places for Replace-Identifying a Foundation Antithrombin Agent in the Setting of PCI
Deepak L.
Bhatt
, MD, FACC, FSCAI,FESC
Interactive Question and Answer Session
Faculty
Panel
